Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)

BACKGROUND: Hypertriglyceridemia in combination with low HDL cholesterol levels is a risk factor for cardiovascular disease. Our objective was to evaluate the efficacy of ciprofibrate for the treatment of this form of dyslipidemia and to identify factors associated with better treatment response. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar-Salinas, Carlos A, Assis-Luores-Vale, Andréia, Stockins, Benjamín, Rengifo, Hector Mario, Filho, José Dondici, Neto, Abrahão Afiune, Rabelo, Lísia Marcílio, Torres, Kerginaldo Paulo, Oliveira, José Egídio Paulo de, Machado, Carlos Alberto, Reyes, Eliana, Saavedra, Victor, Florenzano, Fernando, Hernández, Ma Victoria, Jiménez, Sergio Hernandez, Ramírez, Erika, Vazquez, Cuauhtémoc, Salinas, Saul, Hernández, Ismael, Medel, Octavio, Moreno, Ricardo, Lugo, Paula, Alvarado, Ricardo, Mehta, Roopa, Gutierrez, Victor, Gómez Pérez, Francisco J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC503398/
https://www.ncbi.nlm.nih.gov/pubmed/15272932
http://dx.doi.org/10.1186/1475-2840-3-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC503398/
https://www.ncbi.nlm.nih.gov/pubmed/15272932
http://dx.doi.org/10.1186/1475-2840-3-8

Ejemplares similares